Johnson & Johnson (JNJ) Touches $133.98 High on Jun, 19; Last Week Audioboom Group PLC (LON:BOOM) Coverage

June 19, 2017 - By marketbeat

Among 2 analysts covering Audioboom Group (LON:BOOM), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Audioboom Group had 6 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Liberum Capital with “Buy” on Wednesday, December 14. Beaufort Securities maintained the shares of BOOM in report on Wednesday, March 9 with “Speculative Buy” rating. On Monday, July 27 the stock rating was maintained by Beaufort Securities with “Speculative Buy”. The firm has “Buy” rating given on Tuesday, October 11 by Liberum Capital. The stock of Audioboom Group PLC (LON:BOOM) has “Speculative Buy” rating given on Friday, September 18 by Beaufort Securities. The stock of Audioboom Group PLC (LON:BOOM) earned “Buy” rating by Liberum Capital on Tuesday, March 8. See Audioboom Group PLC (LON:BOOM) latest ratings:

The stock of Johnson & Johnson (NYSE:JNJ) reached all time high today, Jun, 19 and still has $140.68 target or 5.00% above today’s $133.98 share price. This indicates more upside for the $364.47B company. This technical setup was reported by Barchart.com. If the $140.68 PT is reached, the company will be worth $18.22B more. About 787,902 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since June 19, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The company has market cap of $364.47 billion. It operates through three divisions: Consumer, Pharmaceutical and Medical Devices. It has a 22.52 P/E ratio. The Company’s primary focus is products related to human health and well-being.

Among 16 analysts covering Johnson & Johnson (NYSE:JNJ), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Johnson & Johnson had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was upgraded by Goldman Sachs to “Neutral” on Monday, March 14. The rating was upgraded by Barclays Capital on Tuesday, December 1 to “Overweight”. The rating was maintained by Jefferies with “Hold” on Tuesday, September 13. The firm has “Strong-Buy” rating given on Monday, August 31 by Vetr. On Wednesday, October 19 the stock rating was maintained by UBS with “Buy”. As per Friday, December 18, the company rating was initiated by Atlantic Securities. The stock of Johnson & Johnson (NYSE:JNJ) has “Market Perform” rating given on Thursday, January 26 by Wells Fargo. As per Wednesday, January 25, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating by BMO Capital Markets given on Friday, June 2. The firm earned “Outperform” rating on Wednesday, July 20 by RBC Capital Markets.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It improved, as 63 investors sold Johnson & Johnson shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. M Kraus & has invested 3.46% of its portfolio in Johnson & Johnson (NYSE:JNJ). Mairs Power Inc reported 2.14 million shares. Ftb Advsrs has invested 0.93% in Johnson & Johnson (NYSE:JNJ). 1,892 are owned by Consulate. Dnb Asset As, Norway-based fund reported 1.29 million shares. First In holds 0.62% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 9,050 shares. Brookmont Cap Management has 76,828 shares for 3.49% of their portfolio. Burns J W Ny has 58,994 shares for 1.99% of their portfolio. Michigan-based Provident Inv Management Incorporated has invested 0.1% in Johnson & Johnson (NYSE:JNJ). Boothbay Fund Management Ltd Liability Corp has invested 0.12% of its portfolio in Johnson & Johnson (NYSE:JNJ). Bremer Trust Natl Association holds 0.69% or 21,704 shares. Steinberg Glob Asset Mngmt invested in 18,776 shares. Peloton Wealth Strategists owns 1.21% invested in Johnson & Johnson (NYSE:JNJ) for 12,850 shares. Philadelphia holds 14,179 shares or 0.13% of its portfolio. Efg Asset Management (Americas) has 8,093 shares for 0.42% of their portfolio.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 18. They expect $1.78 earnings per share, up 2.30% or $0.04 from last year’s $1.74 per share. JNJ’s profit will be $4.84 billion for 18.82 P/E if the $1.78 EPS becomes a reality. After $1.83 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.73% negative EPS growth.

Since February 1, 2017, it had 0 buys, and 5 insider sales for $14.98 million activity. $6.18M worth of Johnson & Johnson (NYSE:JNJ) was sold by Duato Joaquin. 14,543 shares were sold by Kapusta Ronald A, worth $1.78M. Pruden Gary J also sold $1.99 million worth of Johnson & Johnson (NYSE:JNJ) shares. 22,000 shares were sold by Stoffels Paulus, worth $2.58 million. Another trade for 21,735 shares valued at $2.45M was sold by Ullmann Michael H.

About shares traded. Audioboom Group PLC (LON:BOOM) has 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: